Loop Genomics
Loop Genomics is a San Jose-based platform technology company developing long-read DNA sequencing solutions, founded in 2015 with backing from Khosla Ventures and Y Combinator.
- Company typePrivate
- Founded2017
- HeadquartersSan Jose, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Loop Genomics does
Loop Genomics is a privately held platform technology company developing long-read DNA sequencing solutions, founded in 2015 and headquartered in San Jose, California. The company operates with a small team of 1-10 employees and focuses on a sequencing platform capability that addresses genomic analysis needs not well served by short-read sequencing technologies. Its public presence is anchored at loopgenomics.com.
The company has secured capital from a syndicate of early-stage venture investors. Its largest disclosed capital event is an $8 million Series A round closed in November 2018, led by Khosla Ventures with participation from DN Capital, Fusion Fund, Wilson Sonsini Goodrich & Rosati, Wisemont Capital, and Y Combinator. Earlier funding includes a $120,000 seed round led by Y Combinator in March 2016 and additional pre-seed capital from 11.2 Capital, Rising Tide, and TSVC in April 2016. The most recent disclosed investor engagement is a January 2021 round from Page One Ventures. Total disclosed funding raised is approximately $8.12 million.
The firm's modest capital base, small headcount, and absence of disclosed product line, pricing, customer, or revenue metrics indicate an early-stage commercial posture. No go-to-market motion, customer segment focus, or commercial traction data is documented in the available source material, and no AI/ML capability, regulatory milestones, or competitive positioning statements are attributable to Loop Genomics in the input data.
Loop Genomics firmographics
Firmographics- Name
- Loop Genomics
- Legal name
- Element Biosciences, Inc.
- Website
- https://loopgenomics.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Loop Genomics is a San Jose-based platform technology company developing long-read DNA sequencing solutions, founded in 2015 with backing from Khosla Ventures and Y Combinator.
- Ownership category
- akta.pro rank
Loop Genomics industry classification
Industry- Product category
- Long-Read DNA Sequencing Technology
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- akta.pro primary industry
- Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)
- akta.pro secondary industries
- Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)
Keywords
Where Loop Genomics is headquartered
LocationHeadquarters
- HQ city
- San Jose
- HQ country
- United States
- HQ region
- North America
Markets served
Loop Genomics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D
Revenue model
- Instruments: Sale of sequencing instruments including AVITI24, AVITI, and AVITI LT platforms
- Reagents & Consumables: Recurring revenue from Cloudbreak Sequencing Kits, Trinity Sequencing Kits, Elevate Library Adapters, Adept Library Adapters, and Teton CytoProfiling Kits
- Software Licenses: Software products including ElemBio Cloud and ElemBio Catalyst
- Lab Services: Technology Access Program and service offerings for customers needing external support
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Loop Genomics product offering
Product offeringCore offering
Loop Genomics provides a platform technology for long-read DNA sequencing. The company develops and offers technology that enables long-read sequencing applications for genomics research customers, operating from San Jose, California with a small focused team. The offering addresses the specialized segment of the genomics tools market where long-read sequencing capability is required.
Product overview
Element Biosciences offers a multiomics platform architecture centered on the AVITI instrument family. The core offerings include the AVITI24 (5D multiomics system for spatial single cell analysis), AVITI and AVITI LT (benchtop sequencers), and VITARI (high-throughput platform on 2026 roadmap). The platform is supported by Cloudbreak and Trinity reagent kits, Teton CytoProfiling kits, and Elevate/Adept library adapters. Software consists of ElemBio Cloud for data management and ElemBio Catalyst for workflow control. The company's proprietary Avidite Base Chemistry (ABC) powers all sequencing and multiomics capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- AVITI: Sequencing system platform offering high-quality affordable sequencing
- AVITI24
- VITARI
- Avidite Base Chemistry (ABC)
- Cloudbreak Sequencing Kits
- Trinity Sequencing Kits
- Teton CytoProfiling Kits
- ElemBio Cloud
- ElemBio Catalyst
- Elevate Library Adapters
- Adept Library Adapters
- Direct In Sample Sequencing (DISS)
- Labsolutely Everything
Products and services
- Long-read DNA sequencing platform technology
Quantifiable outcome
- Measurably higher percent unique alignment to hg38 compared to other platforms
- +4 more outcomes
Companies that use Loop Genomics
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles1 record
Loop Genomics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Loop Genomics partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- 10x GenomicscoreTechnology partnership where AVITI System has achieved Cell Propulsion Protocol (CPP) requirements for single cell analysis, expanding customer options for accessing 10x Genomics technology on Element's platform
- Jumpcode GenomicscoreCustomer partnership with positive validation of AVITI System performance showing higher unique alignment rates and lower duplication compared to other sequencing platforms
- Google Health GenomicscoreCustomer partnership validating Element data quality with reduced error rates in difficult contexts, relevant for applications including somatic detection and cell-free DNA analysis
Scale indicators4 records
Recent moves4 records
Expansion highlights1 record
Loop Genomics competitors and assessment
Company assessmentDirect peers
- Pacific Biosciences: Pacific Biosciences is the leading long-read DNA sequencing platform company (HiFi/Sequel systems). Direct peer: both target long-read sequencing customers with similar applications and compete for the same research and clinical-research budgets as Loop Genomics.
- Oxford Nanopore Technologies: Oxford Nanopore develops nanopore-based long-read sequencing platforms (minION, GridION, promethION). Direct peer: directly competes in long-read sequencing and serves overlapping academic, clinical, and field-deployable use cases.
- Element Biosciences: Element Biosciences develops benchtop sequencing and multiomics platforms (AVITI, AVITI24) powered by proprietary Avidite Base Chemistry. Direct peer: competes in the DNA-sequencing instruments market for academic, pharma, and clinical-research customers alongside Loop Genomics.
- Ultima Genomics: Ultima Genomics is developing high-throughput, low-cost sequencing platforms aimed at genomics-scale applications. Direct peer: competes for sequencing-instrument capital budgets and shares a goal of lowering cost-per-genome in research and clinical markets.
- Singular Genomics: Singular Genomics develops benchtop sequencing systems (G4) targeting multiomics and targeted sequencing. Direct peer: addresses overlapping research and translational customers with a comparable benchtop-form-factor value proposition.
Broad incumbents
- Illumina: Illumina is the dominant short-read sequencing incumbent with a global installed base and a broad genomics portfolio. Broad incumbent: not focused on long-read, but its pricing power, reagent ecosystem, and customer relationships set the competitive ceiling for entrants like Loop Genomics.
- MGI Tech: MGI Tech (BGI Group) offers DNBSEQ sequencing platforms and is expanding into multiomics. Broad incumbent: competes in benchtop and production-scale sequencing for global research and clinical customers, including in geographies where Illumina is restricted.
- 10x Genomics: 10x Genomics provides single-cell, spatial, and linked-read genomics solutions built atop sequencing platforms. Broad incumbent: not a sequencing-instrument maker, but its consumables and partnerships with platform owners shape customer demand for long-read-capable workflows adjacent to Loop Genomics' applications.
- QIAGEN: QIAGEN provides sample-prep, NGS library prep, and bioinformatics solutions used across sequencing workflows. Broad incumbent: its consumables sit upstream of sequencing and represent an adjacent, partially-overlapping commercialization pathway for genomics-platform companies like Loop Genomics.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights4 records
Customer concentration
Loop Genomics social profiles
Digital presenceLoop Genomics compliance and trust
Trust signalCompliance1 record
Loop Genomics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Loop Genomics leadership team
Management profileNumber of profiles
Loop Genomics funding detail
Funding detailFunding overview
Funding rounds5 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Loop Genomics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Loop Genomics
What does Loop Genomics do?
Loop Genomics provides a platform technology for long-read DNA sequencing. The company develops and offers technology that enables long-read sequencing applications for genomics research customers, operating from San Jose, California with a small focused team. The offering addresses the specialized segment of the genomics tools market where long-read sequencing capability is required.
Is Loop Genomics a public or private company?
Loop Genomics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Loop Genomics founded?
Loop Genomics was founded in 2017. It employs 1 to 10 people.
Where is Loop Genomics based?
Loop Genomics is headquartered in San Jose, United States, in the North America region.
How does Loop Genomics make money?
Four revenue lines are on record. Instruments are the primary driver. The others are reagents & Consumables, software Licenses and lab Services.
Who are Loop Genomics's main competitors?
Direct peers on record are Pacific Biosciences, Oxford Nanopore Technologies, Element Biosciences, Ultima Genomics and Singular Genomics. Broad incumbents are Illumina, MGI Tech, 10x Genomics and QIAGEN.
Does Loop Genomics have an API?
No public API is recorded for Loop Genomics.
What industry is Loop Genomics in?
Loop Genomics's product category is Long-Read DNA Sequencing Technology. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAGAEAD, Genomics & Molecular Diagnostics (Trial Support). Its NAICS code is 541714.